# OnCo record sanofi (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/sanofi/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "sanofi" ;
  schema:name "Sanofi"@en ;
  schema:alternateName "Genzyme"@en, "Genzyme, a Sanofi Company"@en, "Kiadis Pharma"@en, "Aventis Pharmaceuticals"@en, "Aventis"@en, "ILEX Oncology Services, Incorporated"@en, "ILEX Oncology"@en, "Shantha Biotechnics Limited"@en, "Shantha Biotechnics"@en ;
  schema:description "Sanofi makes Sarclisa (isatuximab), now in a subcutaneous form approved in July 2026."@en ;
  schema:url <https://onco.cc/companies/sanofi/>, <https://www.sanofi.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.sanofi.com> ;
  schema:addressCountry "FR" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/elenestinib/>, <https://onco.cc/drugs/adg126/>, <https://onco.cc/drugs/buserelin/>, <https://onco.cc/drugs/fludarabine/> ;
  onco:companies <https://onco.cc/companies/amunix-pharmaceuticals/>, <https://onco.cc/companies/blueprint-medicines/> ;
  onco:trials <https://onco.cc/trials/nct05704049/>, <https://onco.cc/trials/nct03731260/>, <https://onco.cc/trials/nct07692204/>, <https://onco.cc/trials/nct04270409/>, <https://onco.cc/trials/nct07629960/>, <https://onco.cc/trials/nct05584670/> .